In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

IPO nets $50.9mm for China Kanghui Holdings

Executive Summary

Orthopedic implant developer China Kanghui Holdings has netted $50.9mm through its US initial public offering of 5.34mm American Depositary Shares at $10.25 each. (One ADS represents six ordinary shares.) Selling stockholders offered another 1.3mm shares. The company will trade on the NYSE under the ticker KH.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies